ranulocyte Meeting
The
Granulocyte
Meeting
The next frontier in innate immunology
Monday, 6th November 2023 4:00PM GMT+08:00
-
Thursday, 9th November 2023 1:00PM GMT+08:00
Duke-NUS Medical School,
8 College Rd, Singapore 169857
ABOUT
The Granulocyte Meeting, Singapore
The granulocyte meeting was created to bring together leading experts in granulocyte biology to spearhead the next steps and breakthroughs in innate immunity and the multi-faceted roles granulocytes play in health and diseases. This is the inaugural meeting and the first major event in the South Pacific region, hoping to galvanise the local and regional communities in accelerating the research landscape of granulocyte biology. Come and connect with like-minded and passionate individuals, and learn from each other the challenges and opportunities in harnessing the growing discoveries in granulocytes.
Singapore is the ideal location for our meeting due to its strategic location, state-of-the-art facilities, and cultural diversity. As a global financial hub and transportation hub, Singapore is easily accessible from various parts of the world. Additionally, it boasts world-class conference venues, accommodation options, and efficient transportation systems. The city is also known for its safety and political stability, providing a secure environment for attendees to focus on the conference's goals. Finally, Singapore's multiculturalism offers a unique experience for conference attendees to explore and enjoy during their free time.
Our
Speakers
Keynote Speaker
Stephen Galli
Stanford University
Stephen J. Galli, MD, is the former Chair of Pathology (1999-2016) and current Mary Hewitt Loveless, MD Professor and Professor of Pathology and of Microbiology and Immunology at Stanford University. He is also a member of the Executive Committee of the Stanford Institute for Immunity, Transplantation and Infection. He received his BA and MD from Harvard Medical School, did a residency in Anatomic Pathology at Massachusetts General Hospital, and served as Professor of Pathology on the faculty of Harvard Medical School and Beth Israel Deaconess Medical Center until 1999. His research focuses on the development and function of mast cells and basophils (major effector cells in allergic disorders) and the design of animal models for studying the roles of these cells in health and disease. He has particular interests in the roles of these cells in anaphylaxis, food allergies, and asthma, and in the importance of mast cells and IgE in innate and acquired host defense against venoms. He was President of the American Society for Investigative Pathology (ASIP, 2005-2006) and belongs to several honorary societies including the Collegium Internationale Allergologicum (President, 2010-2014), Pluto Club (American Association of University Pathologists; President, 2018-2019), the National Academy of Medicine (currently, Chair of Section 4), and the Accademia Nazionale dei Lincei in Rome. Dr. Galli received a MERIT Award from the NIAID/NIH (1995-2006), Scientific Achievement Awards from the International Association of Allergy & Clinical Immunology (1997) and the World Allergy Organization (2011), the Rous-Whipple Award of the ASIP (2014), and the Karl Landsteiner Medal of the Austrian Society for Allergology and Immunology (2014).
Confirmed Speakers
Andrés Hidalgo
Ankur Sharma
Ariel Munitz
Ashley St. John
Florent Ginhoux
Hajime Karasuyama
H. Leighton "Lee" Grimes
Ido Amit
Irina Udalova
Isabelle Arnold
Jadwiga Jablonska
​
​
​
Jessica Strid
Nicola Harris
Magnus Åbrink
Matthias Gunzer
Oliver Soehnlein
Paul Kubes
Sarah Walmsley
Shi Lihong
Sofia De Oliveira
Soman Abraham
Sussan Nourshargh
Zhang Yiyue
Sponsors
The
Venue
ABOUT THIS VENUE:
Duke-NUS is Singapore's premier graduate-entry medical school, founded through a collaboration between Duke University and the National University of Singapore. The institution's objective is to provide innovative education and impactful research that advances medical practice in Singapore and beyond. Duke-NUS's MD curriculum aims to produce outstanding clinicians who are also curious, critical thinkers that can contribute to medicine as researchers, educators, leaders, entrepreneurs, or policymakers. In addition to its education programs, Duke-NUS is a research powerhouse focused on critical areas of public health needs. Its strategic partnership with Singapore Health Services (SingHealth), including the Singapore General Hospital, has enabled the development of exceptional clinical education and research collaborations that translate fundamental science into better health.
FULL ADDRESS:
8 College Rd,
Singapore 169857
Organising Committee
​
Co-Organisers
Janessa Tan
Duke-NUS Medical School
Zvi Fridlender
The Hebrew University-Hadassah Medical School
Zvika Granot
Hebrew University of Jerusalem
Committee Members
Anand Andiappan
Singapore Immunology Network, A*STAR
Chinmay K Mantri
Duke-NUS Medical School
Melissa Ng
Singapore Immunology Network, A*STAR
Immanuel Kwok
Singapore Immunology Network, A*STAR